Viewing Study NCT03494569

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2026-05-27 @ 12:35 PM
Study NCT ID: NCT03494569
Status: RECRUITING
Last Update Posted: 2025-11-07
First Post: 2018-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome
Sponsor: City of Hope Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
None Acute Lymphoblastic Leukemia in Remission View
None Acute Myeloid Leukemia View
None Acute Myeloid Leukemia in Remission View
None Hematopoietic Cell Transplantation Recipient View
None Minimal Residual Disease View
None Myelodysplastic Syndrome View
None Secondary Acute Myeloid Leukemia View
Keywords: